Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 4-((1s)-1-((3-(difluoromethyl)-1-methyl-5-(3-(trifluoromethyl)phenoxy)pyrazole-4-carbonyl)amino)ethyl)benzoic Acid
2. E7046
1. 1369489-71-3
2. E7046
3. E-7046
4. Er-886046
5. Palupiprant
6. Ywy620gu8i
7. (s)-4-(1-(3-(difluoromethyl)-1-methyl-5-(3-(trifluoromethyl)phenoxy)-1h-pyrazole-4-carboxamido)ethyl)benzoic Acid
8. 4-[(1s)-1-[[3-(difluoromethyl)-1-methyl-5-[3-(trifluoromethyl)phenoxy]pyrazole-4-carbonyl]amino]ethyl]benzoic Acid
9. 4-[(1s)-1-[[[3-(difluoromethyl)-1-methyl-5-[3-(trifluoromethyl)phenoxy]-1h-pyrazol-4-yl]carbonyl]amino]ethyl]-benzoic Acid
10. Unii-ywy620gu8i
11. Palupiprant [inn]
12. Schembl881212
13. Chembl3670685
14. Bdbm119448
15. E 7046 [who-dd]
16. Bcp25989
17. Ex-a1726
18. Nsc804040
19. S6649
20. Er 886046 [who-dd]
21. Akos037644995
22. Cs-7559
23. Nsc-804040
24. E7046 Pound Er-886406 Pound(c)
25. Ac-30338
26. As-55893
27. Er 886046
28. Hy-103088
29. E 7046
30. Us8686018, 107
31. Q27294756
32. 4-((1s)-1-(((3-(difluoromethyl)-1-methyl-5-(3-(trifluoromethyl)phenoxy)-1h-pyrazol-4-yl)carbonyl)amino)ethyl)benzoic Acid
33. 4-[(1s)-1-{[3-(difluoromethyl)-1-methyl-5-[3-(trifluoromethyl)phenoxy]pyrazol-4-yl]formamido}ethyl]benzoic Acid
| Molecular Weight | 483.4 g/mol |
|---|---|
| Molecular Formula | C22H18F5N3O4 |
| XLogP3 | 4.3 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 10 |
| Rotatable Bond Count | 7 |
| Exact Mass | g/mol |
| Monoisotopic Mass | g/mol |
| Topological Polar Surface Area | 93.4 |
| Heavy Atom Count | 34 |
| Formal Charge | 0 |
| Complexity | 717 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
59
PharmaCompass offers a list of Palupiprant API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Palupiprant manufacturer or Palupiprant supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Palupiprant manufacturer or Palupiprant supplier.
PharmaCompass also assists you with knowing the Palupiprant API Price utilized in the formulation of products. Palupiprant API Price is not always fixed or binding as the Palupiprant Price is obtained through a variety of data sources. The Palupiprant Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Palupiprant manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Palupiprant, including repackagers and relabelers. The FDA regulates Palupiprant manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Palupiprant API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Palupiprant supplier is an individual or a company that provides Palupiprant active pharmaceutical ingredient (API) or Palupiprant finished formulations upon request. The Palupiprant suppliers may include Palupiprant API manufacturers, exporters, distributors and traders.
Palupiprant Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Palupiprant GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Palupiprant GMP manufacturer or Palupiprant GMP API supplier for your needs.
A Palupiprant CoA (Certificate of Analysis) is a formal document that attests to Palupiprant's compliance with Palupiprant specifications and serves as a tool for batch-level quality control.
Palupiprant CoA mostly includes findings from lab analyses of a specific batch. For each Palupiprant CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Palupiprant may be tested according to a variety of international standards, such as European Pharmacopoeia (Palupiprant EP), Palupiprant JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Palupiprant USP).
